Evidence map›Paper›PMID 34951746›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.

Andrew H Karaba, Xianming Zhu, Tao Liang, Kristy H Wang, Alex G Rittenhouse, Olivia Akinde, Yolanda Eby, Jessica E Ruff, Joel N Blankson, Aura T Abedon and 13 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 62 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 3 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Pooled it
  2. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Omicron Infections in Vaccinated Pediatric Solid Organ Transplant Recipients.Journal of the Pediatric Infectious Diseases Society · 2024
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Andrew H KarabaDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-2785-317X
Xianming ZhuDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Tao LiangDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Kristy H WangDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Alex G RittenhouseDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Olivia AkindeDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Yolanda EbyDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jessica E RuffDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Joel N BlanksonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Aura T AbedonDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0001-8083-6964
Jennifer L AlejoDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-3137-9271
Andrea L CoxDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Justin R BaileyDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Elizabeth A ThompsonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Sabra L KleinDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Daniel S WarrenDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jacqueline M Garonzik-WangDepartment of Surgery, University of Wisconsin School of Medicine and Health, Madison, Wisconsin.
Brian J BoyarskyDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0001-6902-9854
Ioannis SitarasW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Andrew PekoszDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Dorry L SegevDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0002-1924-4801
Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
William A WerbelDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-2943-5895
Johns Hopkins University · USBloomberg (United States) · USUniversity of Wisconsin–Madison · US

Funding

HOPE in Action: A Clinical Trial of HIV-to-HIV Liver TransplantationU01AI138897 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Christine Marie Durand, DORRY L. SEGEV · 2018 to 2026
$25.5M
Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Virology Resource CoreU54CA260492 · NCI · JOHNS HOPKINS UNIVERSITY · PI KLEIN, SABRA L. · 2020 to 2024
$10.4M
Clinical and Laboratory Research Training for Gastrointestinal SurgeonsT32DK007713 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DAVID J HACKAM · 1996 to 2026
$5.2M
Unlocking the Potential of HIV-Infected Deceased Donors for Organ TransplantationR01AI120938 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2016 to 2021
$4.3M
Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2K08AI156021 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KARABA, ANDREW HOOVER · 2021 to 2025
$994k
Patient Oriented Research in Solid Organ TransplantationK24AI144954 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGEV, DORRY L. · 2020 to 2024
$956k
The Landscape of Serious Infections following Kidney Transplantation in People Living with HIVK23AI157893 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WERBEL, WILLIAM · 2021 to 2025
$847k
Aggressive Center Report Cards to Safely Increase Transplantation of Suboptimal KidneysK23DK115908 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI GARONZIK WANG, JACQUELINE M · 2018 to 2021
$516k
Aggressive Organ Procurement Organization Report Cards to Safely Increase Kidney TransplantationF32DK124941 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BOYARSKY, BRIAN · 2020 to 2020
$81k
NCI NIH HHS U54CA260491NCI NIH HHS U54 CA260492NIAID NIH HHS HHSN272201400007CNIAID NIH HHS K08 AI156021NIAID NIH HHS K23 AI157893NIAID NIH HHS K24 AI144954NIAID NIH HHS R01 AI120938NIAID NIH HHS U01 AI138897NIDDK NIH HHS F32 DK124941NIDDK NIH HHS K23 DK115908NIDDK NIH HHS T32 DK007713NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

Vaccine-induced SARS-CoV-2 antibody responses are attenuated in solid organ transplant recipients (SOTRs) and breakthrough infections are more common. Additional SARS-CoV-2 vaccine doses increase anti-spike IgG in some SOTRs, but it is uncertain whether neutralization of variants of concern (VOCs) is enhanced. We tested 47 SOTRs for clinical and research anti-spike IgG, pseudoneutralization (ACE2 blocking), and live-virus neutralization (nAb) against VOCs before and after a third SARS-CoV-2 vaccine dose (70% mRNA, 30% Ad26.COV2.S) with comparison to 15 healthy controls after two mRNA vaccine doses. We used correlation analysis to compare anti-spike IgG assays and focused on thresholds associated with neutralization. A third SARS-CoV-2 vaccine dose increased median total anti-spike (1.6-fold), pseudoneutralization against VOCs (2.5-fold vs. Delta), and neutralizing antibodies (1.4-fold against Delta). However, neutralization activity was significantly lower than healthy controls (p < .001); 32% of SOTRs had zero detectable nAb against Delta after third vaccination compared to 100% for controls. Correlation with nAb was seen at anti-spike IgG >4 Log

Indexed as

COVID-19Organ TransplantationAd26COVS1Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesHumansmRNA VaccinesSARS-CoV-2Transplant RecipientsVaccines, SyntheticAd26COVS1Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesmRNA VaccinesVaccines, Syntheticbasic (laboratory) research/scienceimmunobiologyinfection and infectious agents - viralinfectious diseaseSARS-CoV-2/COVID-19solid organ transplantationtranslational research/sciencevaccine

Identifiers

PMID34951746
PMCPMC8983554
OpenAlexW4200248237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.